Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Polypeptides with neuroprotective/neurotrophic activity

June 14, 1996

Cephalon research reveals active compounds

June 14, 1996

RPR's riluzole approved in Europe

June 14, 1996

Myotrophin still pending full marketing approval

June 14, 1996

Lithium/nimodipine combination as bipolar I manic disorder treatment

June 14, 1996

Drug candidate for schizophrenia awaits clinical trials

June 14, 1996

Lilly reports metabotropic glutamate receptor antagonists

June 14, 1996

SmithKline Beecham describes 5-HT1D antagonists

June 14, 1996

Compounds with melatonin receptor affinity from Takeda

June 14, 1996

5-HT2B/2C antagonists reported by SmithKline Beecham

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...